FDA.reportPublic FDA data

deflazacort 36 MG Oral Tablet

RxCUI
1870958
RxNorm name
deflazacort 36 MG Oral Tablet
Display name
deflazacort 36 MG Oral Tablet
Full name
deflazacort 36 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 11 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DeflazacortDEFLAZACORTDoppel Farmaceutici S.r.l.34a03eb7-74f5-4471-e063-6394a90aca632026-08-27Warnings, Adverse reactionsExact identifier
rxcui: 1870958
JAYTHARIDEFLAZACORTDoppel Farmaceutici S.r.l.3542a1e3-acfd-6b9a-e063-6394a90a94662026-08-27Warnings, Adverse reactionsExact identifier
rxcui: 1870958
DeflazacortDEFLAZACORTZydus Pharmaceuticals (USA) Inc.f99fde7c-91ac-4d67-bd76-2b18a1d31f7d2026-07-23Warnings, Adverse reactionsExact identifier
rxcui: 1870958
JAYTHARIDEFLAZACORTZydus Pharmaceuticals (USA) Inc.ced839ee-1131-45c6-9e38-cc81d85daf1c2026-07-23Warnings, Adverse reactionsExact identifier
rxcui: 1870958
DeflazacortDEFLAZACORTUpsher-Smith Laboratories, LLC40818600-3ff0-4c9c-8e31-2001425a7dc92026-07-06Warnings, Adverse reactionsExact identifier
rxcui: 1870958
DeflazacortDEFLAZACORTAurobindo Pharma Limited77d7525d-89c9-4fde-a6a8-0a463fd6cfeb2026-06-01Warnings, Adverse reactionsExact identifier
rxcui: 1870958
DeflazacortDEFLAZACORTAvKARE459b75a2-3242-3048-e063-6394a90ab8822025-12-10Warnings, Adverse reactionsExact identifier
rxcui: 1870958
DeflazacortDEFLAZACORTSun Pharmaceutical Industries, Inc.fb5350d5-ead1-41f4-8b25-0da0bd7fcffe2025-12-09Warnings, Adverse reactionsExact identifier
rxcui: 1870958
EMFLAZADEFLAZACORTPTC Therapeutics, Inc.31b347d2-f156-4055-9d8f-7cf0df4202962025-11-13Warnings, Adverse reactionsExact identifier
rxcui: 1870958
KYMBEEDEFLAZACORTUpsher-Smith Laboratories, LLC89365f9f-a7ae-40d3-aecc-e4add75d21c22025-07-17Warnings, Adverse reactionsExact identifier
rxcui: 1870958
DeflazacortDEFLAZACORTAmneal Pharmaceuticals NY LLC18518568-a40b-41cb-91ce-44fbb55579712025-06-16Warnings, Adverse reactionsExact identifier
rxcui: 1870958

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 9 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
31b347d2-f156-4055-9d8f-7cf0df420296deflazacort 36 MG Oral Tablet [PSN] · deflazacort 36 MG Oral Tablet [SCD]221These highlights do not include all the information needed to use EMFLAZA ® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA ® (deflazacort) tablets, for oral use EMFLAZA ® (deflazacort) oral suspension Initial U.S. Approval: 201720251113
40818600-3ff0-4c9c-8e31-2001425a7dc9deflazacort 36 MG Oral Tablet [PSN] · deflazacort 36 MG Oral Tablet [SCD]26These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS. DEFLAZACORT tablets, for oral use Initial U.S. Approval: 201720250501
18518568-a40b-41cb-91ce-44fbb5557971deflazacort 36 MG Oral Tablet [PSN] · deflazacort 36 MG Oral Tablet [SCD]23These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS . DEFLAZACORT tablets, for oral use Initial U.S. Approval: 201720250616
f99fde7c-91ac-4d67-bd76-2b18a1d31f7ddeflazacort 36 MG Oral Tablet [PSN] · deflazacort 36 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS DEFLAZACORT tablets, for oral use Initial U.S. Approval:201720251217
fb5350d5-ead1-41f4-8b25-0da0bd7fcffedeflazacort 36 MG Oral Tablet [PSN] · deflazacort 36 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS. DEFLAZACORT tablets, for oral use Initial U.S. Approval: 201720251209
ced839ee-1131-45c6-9e38-cc81d85daf1cdeflazacort 36 MG Oral Tablet [PSN] · deflazacort 36 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use JAYTHARI safely and effectively. See full prescribing information for JAYTHARI JAYTHARI (deflazacort) tablets, for oral use Initial U.S. Approval:201720250519
77d7525d-89c9-4fde-a6a8-0a463fd6cfebdeflazacort 36 MG Oral Tablet [PSN] · deflazacort 36 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS. DEFLAZACORT tablets, for oral use Initial U.S. Approval: 201720240613
459b75a2-3242-3048-e063-6394a90ab882deflazacort 36 MG Oral Tablet [PSN] · deflazacort 36 MG Oral Tablet [SCD]21DEFLAZACORT tablets, for oral use These highlights do not include all the information needed to use DEFLAZACORT TABELTS safely and effectively. See full prescribing information for DEFLAZACORT TABELTS Initial U.S. Approval: 201720251210
89365f9f-a7ae-40d3-aecc-e4add75d21c2deflazacort 36 MG Oral Tablet [PSN] · deflazacort 36 MG Oral Tablet [SCD]21HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KYMBEE safely and effectively. See full prescribing information for KYMBEE. KYMBEE TM (deflazacort) tablets, for oral use Initial U.S. Approval: 201720250717